Immature T‐cell leukemia (T‐ALL) cell lines were highly sensitive to a single agent and combination treatment with DDR inhibitors WEE1, CHK1, and ATR (Ghelli Luserna Iacobucci et al, 2015; Di Rorà et al, 2019). The gene discussed is ATR; the disease is acute lymphoblastic leukemia.